• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Technologies
    • Balloons
    • Brain-computer interfaces
    • Cardiac Implants
    • Catheters
    • Endoscopes
    • Heart valves
    • Pulsed Field Ablation
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Molding
      • Injection Molding
      • Insert molding
      • Mold Components
    • Tools
  • Materials
    • Advanced Materials
    • Metals
    • Nitinol
    • Plastics
    • Silicone
  • Business
    • Distribution Agreements
    • Legal News
    • Mergers & Acquisitions
    • Partnerships
    • Personnel Moves
  • Regulatory
    • 510(k)
    • CE Mark
    • FDA Breakthrough Designation
    • ISO Certification
    • Pre-Market Approval (PMA)
    • Recalls
  • Suppliers
  • About Us

MedAlliance sirolimus-eluting balloon wins second FDA IDE

August 12, 2022 By Danielle Kirsh

MedAlliance Selution SLR
[Image courtesy of MedAlliance]
MedAlliance this week announced its Selution SLR sirolimus-eluting balloon received conditional FDA investigational device exemption (IDE) approval to begin a clinical trial for occlusive disease of the superficial femoral artery (SFA).

The second IDE approval comes a few months after the Geneva, Switzerland-based company won IDE approval for the device in the treatment of below-the-knee indication.

Enrollment in the Selution SLR IDE SFA study will begin later this year and will be conducted at over 20 centers in the U.S. and an additional 20 centers globally. MedAlliance plans to enroll 300 patients in the study to demonstrate superiority over balloon angioplasty for treating peripheral artery disease (PAD).

“This is a significant milestone for MedAlliance: we are the first non-paclitaxel drug-coated balloon to receive IDE approval, and now the first to have two applications approved. This is the culmination of a multi-year R&D program to provide the comprehensive non-clinical data required to satisfy the very high standards expected by the US FDA,” CEO Jeffrey Jump said in a news release. “We are very pleased with the rapid level of sales growth we are experiencing in Europe, Asia and South America and very much look forward to entering the US market.”

The study will be conducted by principal investigator Dr. George Adams, director of cardiovascular and peripheral vascular research at Rex Hospital in Raleigh, N.C.

“We are very excited that U.S. patients suffering from PAD will have the opportunity to receive this novel sirolimus drug-coated balloon technology. This is yet another advancement in the field of treating vascular disease and we are confident that this study will enroll quickly,” said Adams.

Selution SLR was granted CE mark approval to treat peripheral artery disease in February 2020 and to treat coronary artery disease in May 2020. It has won four breakthrough device designations in the U.S. for the treatment of atherosclerotic lesions in native coronary arteries; coronary in-stent restenosis; peripheral below-the-knee and AV-fistula indications.

The company enrolled the first patient in its below-the-knee IDE clinical trial in June to demonstrate superior efficacy and equivalent safety for Selution SLR compared to uncoated balloon angioplasty to treat below-the-knee arteries in chronic limb-threatening ischemia patients.

MedAlliance’s Selution SLR has unique MicroReservoirs that are made from a biodegradable polymer that is intermixed with the anti-restenotic drug sirolimus. The MicroReservoirs provide controlled and sustained release of the drug.

Filed Under: Balloons, Catheters Tagged With: MedAlliance

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Tubing + Extrusion, Medical Design & Outsourcing and MassDevice. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Primary Sidebar

“mte
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest trends and developments in medical tubing and extrusion.
MDO ad

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World
Drug Delivery Business News

Medical Tubing + Extrusion

Subscribe to our E-Newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS